vimarsana.com
Home
Live Updates
FDA Clarifies Labeling Expectations for Prescription Drug Us
FDA Clarifies Labeling Expectations for Prescription Drug Us
FDA Clarifies Labeling Expectations for Prescription Drug Use-Related Software | Sheppard Mullin Richter & Hampton LLP
On September 19, 2023, the U.S. Food and Drug Administration (“FDA” or “the Agency”) published a draft guidance, Regulatory Considerations for Prescription Drug Use-Related Software...
Related Keywords
,
Software Function ,
Radiological Health ,
Sheppard Mullin Richter Hampton ,
Software The Guidance ,
Software Functions Device ,
Software Functions ,
Drug Administration ,
Sheppard Mullin Richter ,
Regulatory Considerations ,
Prescription Drug Use Related Software ,
User Output ,
Drug Use Related Software ,
End User Output ,
Prescription Drug Use Related ,
Connected Software ,
User Outputs ,
End User Outputs ,
Promotional Labeling ,
Human Use ,
Drug Evaluation ,
Biologics Evaluation ,
Device Connected Software Function ,
Prescribing Information Resources ,